These outcomes, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a singular technique to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Ailments. Research on conolidine is limited, https://billc172yof8.blogcudinti.com/profile